ARTICLE | Clinical News

LuMeBlue: Ph III data

December 1, 2016 11:41 AM UTC

Top-line data from a double-blind, international Phase III trial in about 1,270 patients undergoing a colonoscopy showed that oral LuMeBlue met the primary endpoint of improving the detection of adeno...

BCIQ Company Profiles

Cosmo Pharmaceuticals N.V.